The global Hospice Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Routine Home Care, Continuous Home Care, Inpatient Respite Care, General Inpatient Care), By Location (Hospice Center, Hospital, Home Hospice Care, Skilled Nursing Facility), By Diagnosis (Dementia, Circulatory/Heart, Cancer, Respiratory, Stroke, Chronic Kidney Disease, Others)
In 2024, the market for hospice services continues to play a crucial role in providing compassionate end-of-life care and support to individuals facing terminal illnesses and their families. Hospice care focuses on enhancing quality of life, managing symptoms, and ensuring comfort and dignity for patients during their final stages of life. Services provided by hospice teams may include pain management, symptom control, emotional and spiritual support, counseling, and assistance with activities of daily living. With an aging population and increasing prevalence of chronic diseases, the demand for hospice services is expected to grow as more individuals seek holistic and personalized care options that prioritize comfort and dignity in their final days. Moreover, advancements in palliative care, interdisciplinary collaboration, and community-based services have expanded access to hospice care for patients in various settings, including home, hospitals, nursing homes, and hospice facilities. As healthcare systems strive to improve end-of-life care, address cultural and spiritual needs, and support patients and families through the dying process, the market for hospice services is poised for continued growth and innovation, offering opportunities for collaboration, education, and advocacy to improve the quality of care and support for patients and families facing life-limiting illnesses.
The market report analyses the leading companies in the industry including Caritas Internationalis, Chemed Corp, Covenant Health and Community Services Inc, Crossroads-Hospice and Palliative Care, Dierksen-Hospice, FC Compassus LLC, Golden Living Centers, Intrepid USA Healthcare Services, LHC GROUP Inc, LifePoint Health Inc, National Association for Home Care and Hospice, Oklahoma Palliative and Hospice-Care, PeaceHealth, ProMedica Health Systems Inc, PruittHealth Corp, Samaritan Health Services, The Ensign Group Inc, and Others.
The hospice market is experiencing a prominent trend towards the increasing preference for home-based hospice care, driven by patient and family preferences, advancements in healthcare technology, and cost-efficiency considerations. As individuals nearing the end of life seek to receive care in familiar and comfortable surroundings, there is a growing demand for hospice services that can be provided in patients' homes, allowing them to remain surrounded by loved ones while receiving compassionate end-of-life care. This trend is fueled by factors such as the desire for personalized care, autonomy in decision-making, and the availability of supportive resources and services in the community, driving market growth and innovation in home-based hospice care models.
A key driver propelling the hospice market is the aging population and the increasing need for end-of-life care services to support individuals with terminal illnesses and their families. With demographic shifts leading to a larger population of elderly individuals and the prevalence of chronic and life-limiting conditions, there is a rising demand for hospice care that focuses on symptom management, pain relief, and emotional support during the end-of-life journey. This driver is further fueled by healthcare reforms emphasizing patient-centered care, palliative care integration, and the recognition of hospice as an essential component of comprehensive healthcare services, driving market growth and expansion in the hospice industry.
An opportunity exists for hospice providers to expand their services to include comprehensive palliative care programs that address the holistic needs of patients and families throughout the continuum of care. By offering palliative care services earlier in the disease trajectory, providers can improve quality of life, alleviate suffering, and enhance patient and family satisfaction while providing a seamless transition to hospice care when needed. Moreover, collaborating with healthcare systems, community organizations, and payers to develop integrated care models, telehealth solutions, and supportive care networks can help expand access to palliative care services and reach underserved populations, creating opportunities for growth and innovation in the hospice and palliative care sector. This opportunity allows providers to meet the evolving needs of patients and families facing serious illness, improve care coordination and outcomes, and advance the delivery of compassionate end-of-life care in diverse settings.
In the Hospice Market, the largest segment is Routine Home Care, primarily due to its emphasis on providing compassionate end-of-life care in the familiar and comforting surroundings of a patient's home. Routine Home Care offers patients and their families the opportunity to receive comprehensive hospice services, including medical care, pain management, emotional support, and spiritual guidance, in the comfort of their own homes. This segment caters to the growing preference among patients for receiving end-of-life care in a familiar environment surrounded by loved ones, rather than in a hospital or institutional setting. Additionally, Routine Home Care promotes a sense of autonomy and dignity for patients as they navigate the final stages of life, fostering a peaceful and supportive environment conducive to emotional healing and closure. Furthermore, advancements in telemedicine and home healthcare technology have further enhanced the accessibility and effectiveness of Routine Home Care, contributing to its dominance in the Hospice Market. As the demand for patient-centered end-of-life care continues to rise, Routine Home Care remains the largest segment in the Hospice Market, poised for sustained growth and market leadership.
In the Hospice Market, the Home Hospice Care segment is the fastest-growing, propelled by the growing preference among patients and their families for receiving end-of-life care in the familiar and comforting surroundings of their own homes. Home Hospice Care offers patients the opportunity to receive comprehensive hospice services, including medical care, pain management, emotional support, and spiritual guidance, in the comfort and privacy of their homes. This segment caters to the desire of patients to maintain their independence, dignity, and quality of life during their final days, surrounded by loved ones and familiar surroundings. Additionally, advancements in telemedicine and home healthcare technology have facilitated the delivery of high-quality hospice care in the home setting, enhancing accessibility and convenience for patients and their families. Furthermore, the COVID-19 pandemic has accelerated the adoption of home-based care options, as patients seek to minimize exposure to healthcare facilities while receiving compassionate end-of-life care. As the demand for patient-centered and personalized hospice care continues to rise, the Home Hospice Care segment experiences rapid growth, poised to reshape the Hospice Market landscape.
Cancer is the largest segment within the hospice market, owing to its pervasive prevalence and complex care needs. With advancements in detection and treatment, more individuals are diagnosed with various forms of cancer, resulting in a heightened demand for specialized end-of-life care. This segment's rapid growth can be attributed to several factors, including an aging population, lifestyle changes, and improved diagnostic techniques leading to earlier detection. Additionally, as societies become more aware of palliative care options, there's a shifting cultural attitude towards embracing hospice services for cancer patients, facilitating the segment's expansion. Further, the multifaceted nature of cancer care, encompassing pain management, emotional support, and symptom alleviation, underscores the necessity for tailored hospice solutions, further propelling the growth of this segment. As cancer remains a leading cause of mortality worldwide, the hospice market's focus on addressing the unique needs of cancer patients is paramount in shaping the landscape of end-of-life care.
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Caritas Internationalis
Chemed Corp
Covenant Health and Community Services Inc
Crossroads-Hospice and Palliative Care
Dierksen-Hospice
FC Compassus LLC
Golden Living Centers
Intrepid USA Healthcare Services
LHC GROUP Inc
LifePoint Health Inc
National Association for Home Care and Hospice
Oklahoma Palliative and Hospice-Care
PeaceHealth
ProMedica Health Systems Inc
PruittHealth Corp
Samaritan Health Services
The Ensign Group Inc
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Hospice Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Hospice Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Hospice Market Share by Company, 2023
4.1.2. Product Offerings of Leading Hospice Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Hospice Market Drivers
6.2. Hospice Market Challenges
6.6. Hospice Market Opportunities
6.4. Hospice Market Trends
Chapter 7. Global Hospice Market Outlook Trends
7.1. Global Hospice Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Hospice Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Hospice Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 8. Global Hospice Regional Analysis and Outlook
8.1. Global Hospice Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Hospice Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Hospice Regional Analysis and Outlook
8.2.2. Canada Hospice Regional Analysis and Outlook
8.2.3. Mexico Hospice Regional Analysis and Outlook
8.3. Europe Hospice Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Hospice Regional Analysis and Outlook
8.3.2. France Hospice Regional Analysis and Outlook
8.3.3. United Kingdom Hospice Regional Analysis and Outlook
8.3.4. Spain Hospice Regional Analysis and Outlook
8.3.5. Italy Hospice Regional Analysis and Outlook
8.3.6. Russia Hospice Regional Analysis and Outlook
8.3.7. Rest of Europe Hospice Regional Analysis and Outlook
8.4. Asia Pacific Hospice Revenue (USD Million) by Country (2021-2032)
8.4.1. China Hospice Regional Analysis and Outlook
8.4.2. Japan Hospice Regional Analysis and Outlook
8.4.3. India Hospice Regional Analysis and Outlook
8.4.4. South Korea Hospice Regional Analysis and Outlook
8.4.5. Australia Hospice Regional Analysis and Outlook
8.4.6. South East Asia Hospice Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Hospice Regional Analysis and Outlook
8.5. South America Hospice Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Hospice Regional Analysis and Outlook
8.5.2. Argentina Hospice Regional Analysis and Outlook
8.5.3. Rest of South America Hospice Regional Analysis and Outlook
8.6. Middle East and Africa Hospice Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Hospice Regional Analysis and Outlook
8.6.2. Africa Hospice Regional Analysis and Outlook
Chapter 9. North America Hospice Analysis and Outlook
9.1. North America Hospice Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Hospice Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Hospice Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Hospice Revenue (USD Million) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 10. Europe Hospice Analysis and Outlook
10.1. Europe Hospice Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Hospice Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Hospice Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Hospice Revenue (USD Million) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 11. Asia Pacific Hospice Analysis and Outlook
11.1. Asia Pacific Hospice Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Hospice Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Hospice Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Hospice Revenue (USD Million) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 12. South America Hospice Analysis and Outlook
12.1. South America Hospice Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Hospice Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Hospice Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Hospice Revenue (USD Million) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 13. Middle East and Africa Hospice Analysis and Outlook
13.1. Middle East and Africa Hospice Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Hospice Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Hospice Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Hospice Revenue (USD Million) by Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Chapter 14. Hospice Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Caritas Internationalis
Chemed Corp
Covenant Health and Community Services Inc
Crossroads-Hospice and Palliative Care
Dierksen-Hospice
FC Compassus LLC
Golden Living Centers
Intrepid USA Healthcare Services
LHC GROUP Inc
LifePoint Health Inc
National Association for Home Care and Hospice
Oklahoma Palliative and Hospice-Care
PeaceHealth
ProMedica Health Systems Inc
PruittHealth Corp
Samaritan Health Services
The Ensign Group Inc
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Hospice Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Hospice Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Hospice Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Hospice Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Hospice Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Hospice Market Share (%) By Regions (2021-2032)
Table 12 North America Hospice Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Hospice Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Hospice Revenue (USD Million) By Country (2021-2032)
Table 15 South America Hospice Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Hospice Revenue (USD Million) By Region (2021-2032)
Table 17 North America Hospice Revenue (USD Million) By Type (2021-2032)
Table 18 North America Hospice Revenue (USD Million) By Application (2021-2032)
Table 19 North America Hospice Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Hospice Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Hospice Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Hospice Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Hospice Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Hospice Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Hospice Revenue (USD Million) By Product (2021-2032)
Table 26 South America Hospice Revenue (USD Million) By Type (2021-2032)
Table 27 South America Hospice Revenue (USD Million) By Application (2021-2032)
Table 28 South America Hospice Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Hospice Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Hospice Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Hospice Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Hospice Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Hospice Market Share (%) By Regions (2023)
Figure 6. North America Hospice Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Hospice Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Hospice Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Hospice Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Hospice Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Hospice Revenue (USD Million) By Country (2021-2032)
Figure 12. France Hospice Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Hospice Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Hospice Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Hospice Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Hospice Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Hospice Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Hospice Revenue (USD Million) By Country (2021-2032)
Figure 12. China Hospice Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Hospice Revenue (USD Million) By Country (2021-2032)
Figure 14. India Hospice Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Hospice Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Hospice Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Hospice Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Hospice Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Hospice Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Hospice Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Hospice Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Hospice Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Hospice Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Hospice Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Hospice Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Hospice Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Hospice Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Hospice Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Hospice Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Hospice Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Hospice Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Hospice Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Hospice Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Hospice Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Hospice Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Hospice Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Hospice Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Hospice Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Hospice Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Hospice Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Hospice Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Hospice Revenue (USD Million) By Product (2021-2032)
By Type
Routine Home Care
Continuous Home Care
Inpatient Respite Care
General Inpatient Care
By Location
Hospice Center
Hospital
Home Hospice Care
Skilled Nursing Facility
By Diagnosis
Dementia
Circulatory/Heart
Cancer
Respiratory
Stroke
Chronic Kidney Disease
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Hospice Market Size is valued at $62.5 Billion in 2024 and is forecast to register a growth rate (CAGR) of 8.3% to reach $118.3 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Caritas Internationalis, Chemed Corp, Covenant Health and Community Services Inc, Crossroads-Hospice and Palliative Care, Dierksen-Hospice, FC Compassus LLC, Golden Living Centers, Intrepid USA Healthcare Services, LHC GROUP Inc, LifePoint Health Inc, National Association for Home Care and Hospice, Oklahoma Palliative and Hospice-Care, PeaceHealth, ProMedica Health Systems Inc, PruittHealth Corp, Samaritan Health Services, The Ensign Group Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume